Deborah Kay Armstrong

Professor

1979 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Platinum Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2018

New therapies for ovarian cancer

Armstrong, D. K. May 1 2018 In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 5S, p. 632-635 4 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Guidelines
Adenosine Diphosphate Ribose
Poly Adenosine Diphosphate Ribose
Therapeutics

OV21/PETROC: A randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Provencher, D. M. , Gallagher, C. J. , Parulekar, W. R. , Ledermann, J. A. , Armstrong, D. K. , Brundage, M. , Gourley, C. , Romero, I. , Gonzalez-Martin, A. , Feeney, M. , Bessette, P. , Hall, M. , Weberpals, J. I. , Hall, G. , Lau, S. K. , Gauthier, P. , Fung-Kee-Fung, M. , Eisenhauer, E. A. , Winch, C. , Tu, D. & 1 others MacKay, H. J. Feb 1 2018 In : Annals of Oncology. 29, 2, p. 431-438 8 p.

Research output: Contribution to journalArticle

Carboplatin
Ovarian Neoplasms
Drug Therapy
Paclitaxel
Neoplasms

OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Provencher, D. M. , Gallagher, C. J. , Parulekar, W. R. , Ledermann, J. A. , Armstrong, D. K. , Brundage, M. , Gourley, C. , Romero, I. , Gonzalez-Martin, A. , Feeney, M. , Bessette, P. , Hall, M. , Weberpals, J. I. , Hall, G. , Lau, S. K. , Gauthier, P. , Fung-Kee-Fung, M. , Eisenhauer, E. A. , Winch, C. , Tu, D. & 1 others Mackay, H. J. Apr 1 2018 In : Obstetrical and Gynecological Survey. 73, 4, p. 209-210 2 p.

Research output: Contribution to journalComment/debate

Drug Therapy
Neoplasms
Ovarian epithelial cancer

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G. L., Jeter, S. C., Armstrong, D., Emens, L. A., Fetting, J., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R. M. Jan 1 2018 (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Confidence Intervals
Stroke Volume
Incidence

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers

Reiss, K. A., Herman, J. M., Armstrong, D., Zahurak, M., Fyles, A., Brade, A., Milosevic, M., Dawson, L. A., Scardina, A., Fischer, P., Hacker-Prietz, A., Kinders, R. J., Wang, L., Chen, A., Temkin, S., Horiba, N., Stayner, L. A., Siu, L. L. & Azad, N. S. Mar 1 2017 In : Gynecologic Oncology. 144, 3, p. 486-490 5 p.

Research output: Contribution to journalArticle

Fallopian Tube Neoplasms
Radiotherapy
Carcinoma
Neoplasms
Platinum